À réviser

The Candidate Blood-stage Malaria Vaccine P27A Induces a Robust Humoral Response in a Fast Track to the Field Phase 1 Trial in Exposed and Nonexposed Volunteers

Viviane Steiner-Monard, Kassim Kamaka, O. Karoui, Samuel Roethlisberger, R. Audran, C. Daubenberger, A. Fayet-Mello, Aude Erdmann-Voisin, I. Felger, Kristina M. Geiger, Lerisa Govender, S. Houard, E. Huber, Carole Mayor, C. Mkindi, D. Portevin, Sebastian Rusch, Sandro Schmidlin, R. Tiendrebeogo, M. Theisen, Anne-Christine Thierry, Laure Vallotton, G. Corradin, O. Leroy, S. Abdulla, S. Shekalaghe, B. Genton, F. Spertini, Said Jongo

À réviser

Lactococcus lactis provides an efficient platform for production of disulfide-rich recombinant proteins from Plasmodium falciparum

Susheel Singh, R. Tiendrebeogo, B. Chourasia, I. H. Kana, Subhash Singh, M. Theisen

À réviser

Expression, Purification and Characterization of GMZ2’.10C, a Complex Disulphide-Bonded Fusion Protein Vaccine Candidate against the Asexual and Sexual Life-Stages of the Malaria-Causing Plasmodium falciparum Parasite

Ulrik H. Mistarz, Susheel Singh, T. T. Nguyen, W. Roeffen, Fen Yang, Casper Lissau, S. Madsen, A. Vrang, R. Tiendrebeogo, I. H. Kana, R. Sauerwein, M. Theisen, K. Rand

À réviser

Malaria epidemiology in an area of stable transmission in tribal population of Jharkhand, India

M. Das, B. K. Prajapati, R. Tiendrebeogo, K. Ranjan, B. Adu, Amit Kumar Srivastava, H. Khera, N. Chauhan, Sanjay Tevatiya, I. H. Kana, S. Sharma, Subhash Singh, M. Theisen

À réviser

Naturally Acquired Antibodies Target the Glutamate-Rich Protein on Intact Merozoites and Predict Protection Against Febrile Malaria

I. H. Kana, B. Adu, R. Tiendrebeogo, Susheel Singh, D. Dodoo, M. Theisen